BOC Sciences

    Country: Country United States

    Business Type: Trading Company

    Premium supplierPremium
    supplier

  • Ms.Linna Green
    Tel: 1-631-485-4226

  • Mobile:
  • Tel:1-631-485-4226
  • Fax:1-631-614-7828
  • URL:https://www.bocsci.com/
  • Province/state:New York
  • City:Shirley
  • Street:Ramsey Road
  • MaxCard:
Home > Products >  Degrasyn

Degrasyn CAS NO.856243-80-6

  • Min.Order: 1 Gram
  • Payment Terms: L/C
  • Product Details

Keywords

  • WP1130
  • WP-1130
  • Degrasyn

Quick Details

  • ProName: Degrasyn
  • CasNo: 856243-80-6
  • Appearance: white solid powder
  • Application: research use
  • DeliveryTime: 7 days
  • PackAge: inquiry
  • Port: inquiry
  • ProductionCapacity: 10 Kilogram/Month
  • Purity: 0.98
  • Transportation: inquiry
  • LimitNum: 1 Gram

Superiority

BOC Sciences is committed to supplying cost-effective products and services. We provide Degrasyn (Cas:856243-80-6). Degrasyn, also known as WP1130, is a small molecule that specifically and rapidly down-regulates both wild-type and mutant Bcr/Abl protein without affecting bcr/abl gene expression in chronic myelogenous leukemia (CML) cells. WP1130 was more effective in reducing leukemic versus normal hematopoietic colony formation and strongly inhibited colony formation of cells derived from patients with T315I mutant Bcr/Abl-expressing CML in blast crisis. WP1130 suppressed the growth of K562 heterotransplanted tumors as well as both wild-type Bcr/Abl and T315I mutant Bcr/Abl-expressing BaF/3 cells transplanted into nude mice. WP1130 may be useful in treating CML.More information please visit the website: #

Details

BOC Sciences is committed to supplying cost-effective products and services. We provide Degrasyn (Cas:856243-80-6). Degrasyn, also known as WP1130, is a small molecule that specifically and rapidly down-regulates both wild-type and mutant Bcr/Abl protein without affecting bcr/abl gene expression in chronic myelogenous leukemia (CML) cells. WP1130 was more effective in reducing leukemic versus normal hematopoietic colony formation and strongly inhibited colony formation of cells derived from patients with T315I mutant Bcr/Abl-expressing CML in blast crisis. WP1130 suppressed the growth of K562 heterotransplanted tumors as well as both wild-type Bcr/Abl and T315I mutant Bcr/Abl-expressing BaF/3 cells transplanted into nude mice. WP1130 may be useful in treating CML.More information please visit the website: #

Other products of this supplier

lookchemhot product CAS New CAS Cas Database Article Data Chemical Catalog

无标题页